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Background and purpose — Osseointegrated implants are an 
alternative for prosthetic attachment in individuals with amputa-
tion who are unable to wear a socket. However, the load transmit-
ted through the osseointegrated fixation to the residual tibia and 
knee joint can be unbearable for those with transtibial amputa-
tion and knee arthritis. We report on the feasibility of combining 
total knee replacement (TKR) with an osseointegrated implant 
for prosthetic attachment.
Patients and methods — We retrospectively reviewed all 4 cases 
(aged 38–77 years) of transtibial amputations managed with osseo-
integration and TKR in 2012–2014. The below-the-knee prosthe-
sis was connected to the tibial base plate of a TKR, enabling the 
tibial residuum and knee joint to act as weight-sharing structures. 
A 2-stage procedure involved connecting a standard hinged TKR 
to custom-made implants and creation of a skin-implant interface. 
Clinical outcomes were assessed at baseline and after 1–3 years 
of follow-up using standard measures of health-related quality of 
life, ambulation, and activity level including the questionnaire for 
transfemoral amputees (Q-TFA) and the 6-minute walk test. 
Results — There were no major complications, and there was 
1 case of superficial infection. All patients showed improved clini-
cal outcomes, with a Q-TFA improvement range of 29–52 and a 
6-minute walk test improvement range of 37–84 meters.
Interpretation — It is possible to combine TKR with osseointe-
grated implants.

Socket-related discomfort leads to a significant reduction in 
the quality of life of individuals with lower limb amputation 
(Dillingham et al. 2001, Gholizadeh et al. 2014). Socket-skin 
interface problems lead to poor fit, diminished proprioception 
in the amputated limb, lack of rotational control, and reduc-
tion of ipsilateral proximal joint movement (Legro et al. 1999, 
Lyon et al. 2000, Meulenbelt et al. 2006).  
A direct connection of the prosthetic limb to the bone using 
osseointegrated implants can address these socket-related 
problems (Van de Meent et al. 2013, Tsikandylakis et al. 
2014). Brånemark introduced this surgical procedure in 1995. 
He adapted osseointegration principles established in dental 
surgery to the rehabilitation of individuals with transfemo-
ral amputation using a percutaneous bone anchoring implant 
screwed into the femur (Brånemark et al. 2001). Hip replace-
ment spongiosa surface coating technology has been used to 
make a chrome cobalt intramedullary press-fit implant (Endo-
Exo Prosthesis) allowing larger surface area for osseointegra-
tion and faster rehabilitation (Staubach and Grundei 2001). Al 
Muderis et al. (2015) adapted highly porous plasma-sprayed 
titanium implants to provide optimum initial press-fit and 
solid bone ingrowth. 
Studies of transfemoral implants have found improved qual-
ity of life, prosthetic use, body image, hip range of motion, 
sitting comfort, and walking ability (Van de Meent et al. 2013, 
Hagberg et al. 2014). For example, substantial improvements 
in health-related quality of life using the Global component 
of the questionnaire for transfemoral amputees (Q-TFA)—of 
38 points (Hagberg et al. 2014) and 24 points (Van de Meent 
et al. 2013)—have been reported in 2 case series of 51 and 22 
patients, respectively. 
Similar benefits could be expected for transtibial amputees 
using osseointegrated implants, as the knee joint could pos-
sibly enhance their gait. A study of 39 cases involving upper 
and lower limb prostheses (Tillander et al. 2010) found infec-
tions in 7 patients at an average follow-up period of 54 (3–132) 
months, with no infections reported for 1 tibial implant. At our 
own center, preliminary evidence of the safety and effective-
ness of the tibial impants in 22 transtibial amputees with a mini-
mum of 6 months of follow-up gave results consistent with the 
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Few authors have reported on the safety of this procedure 
(Brånemark et al. 2014, Tsikandylakis et al. 2014). One of 
the largest studies included 51 patients and reported superfi-
cial infections in approximately half of these patients at 2-year 
follow-up. In that study, the implant was removed in 1 patient 
due to deep infection and in 3 patients due to aseptic loosening 
(Brånemark et al. 2014). 
Osseointegrated implants are not currently recommended 
for transtibial amputees with ultra-short residuum. In addition 
to the practical technical challenges, biomechanical studies 
have suggested that small bone-implant contact is more likely 
to increase the risk of loosening (Lohr et al. 2000, Henriksen 
et al. 2003, Carvalho et al. 2012). Osseointegration is also not 
currently recommended for those suffering from ipsilateral 
knee osteoarthritis because it is hypothesized that an osseoin-
tegrated tibial implant will aggravate arthritic symptoms due 
to mechanical forces (Frossard et al. 2008). 
We describe the surgical procedure and early results of 
combining a total knee replacement (TKR) with an osseoin-
tegrated implant for prosthetic attachment for the first time. 
Patients and methods
We retrospectively reviewed all 4 individuals with transtibial 
amputations who underwent TKR combined with an osseo-
integrated implant at our center. Eligibility criteria included 
transtibial amputees presenting with socket-related problems 
and having arthritis and/or a short residuum (< 40 mm). All 4 
patients were treated at a specialized orthopedic osseointegra-
tion clinic run by the investigators.
Surgical technique
A 2-stage surgical procedure was performed 4–6 weeks apart, 
to connect an osseointegrated tibial prosthesis to the cemented 
tibial base plate of a standard hinged TKR prosthesis, transfer-
ring the load directly to the femur and enabling the tibial resid-
uum and the knee joint to act as weight-sharing structures. 
Implant design
The implant consisted of 4 components. The knee prosthesis 
used was a standard cemented stemmed rotating hinged-knee 
system (Genia R-Pol Endoprosthetic Knee System; Orthody-
namics GmbH, Lübeck, Germany). The tibial osseointegrated 
implant component was made of titanium, plasma-sprayed 
with a rough surface. The dual conus was made from a 
cobalt-chrome alloy coated with titanium niobium. The fourth 
component was a cobalt-chrome taper sleeve. The tibial plat-
form and the dual conus were secured to the osseointegrated 
implant via a locking screw. The implant for each individual 
patient was designed and customized by the principal investi-
gator based on CT scans and plain radiographs (Figures 1 and 
2; for Figure 2, see Supplementary data)
Surgery stage 1
We used spinal anesthesia blockade and 2 g of Cephazolin for 
infection prophylaxis. The knee was opened in layers using 
a midline skin incision and a medial peripatellar arthrotomy 
(Crawford and Coleman 2003). Free-hand tibial plateau resec-
tion was done using a sagittal saw. The tibial medullary canal 
was sequentially broached. The femoral cuts were made using 
a size-specific block and the medullary canal was reamed for 
the stem. The trial components were placed in situ and the 
knee was then taken through a range of motion. An image 
intensifier was used to check the component position (Figure 
4B). Then the definitive components were implanted. 
Surgery stage 2
A guide-wire was used to localize the center of the cannulated 
end-cap using an image intensifier. Passing a coring device 
over the guide-wire, perforating the skin, subcutaneous tissue, 
and the sealed end of the bony residuum, a skin-implant inter-
face was created. The skin was then stitched to the bone using 
intraosseous sutures (2 Nylon). A dual conus was then inserted 
into the tibial component of the implant followed by a screw 
locking the 2 components together. This was in turn followed 
by placing the taper sleeve. 
Postoperative care
Wound care involved daily dressing changes with dry ribbon 
gauze, and sutures were removed after 14 days. This was until 
the wound granulated over the titanium niobium oxide-pol-
ished surface of the dual conus. Thereafter, the patients were 
instructed to wash the implant-skin interface with warm tap 
water and soap, and to pat dry.
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Rehabilitation
All the patients followed a modified version of the Osseoin-
tegration Group of Australia Accelerated Protocol (OGAAP) 
for postoperative care and rehabilitation, which integrated 
guidelines for TKR and osseointegration fixations (Khemka 
et al. 2015). 
Patients mobilized without weight bearing using a forearm 
support frame and assisted by physiotherapists. Knee motion 
and core strengthening also commenced on day 1.
Following the second stage of rehabilitation involved axial 
loading of 20 kg twice a day for 20 min, with an increment of 
5 kg per day until reaching 50 kg or half of their body weight. 
Balance and gait training was commenced once the patients 
were fitted with a prosthesis. They were allowed to mobi-
lize with full weight bearing using 2 crutches for 6 weeks, 
followed by another 6-week period with a single crutch and 
unaided thereafter.  
Outcomes
Clinical and functional outcomes were measured at baseline 
and at a minimum of 1 year of follow-up. Plain radiographs 
were taken at baseline, at 3, 6, and 12 months, and then on an 
annual basis. Skin-implant interface was monitored, looking 
at discharge and granulation. Adverse events were monitored.
Functional outcomes were assessed using the physical 
and mental components of the Short Form 36 (SF-36) health 
survey as well as the questionnaire for transfemoral ampu-
tees (Q-TFA) (Ware 1999, Hagberg et al. 2004). The Q-TFA 
was initially developed and validated for use by transfemoral 
amputees. However, it assesses aspects that are also relevant 
and meaningful for transtibial amputees: a prosthetic use score 
(amount of prosthetic wear per week), prosthetic mobility 
score (prosthetic capability, aids, and habits), problem score 
(problems related to amputation and prosthesis affecting qual-
ity of life), and global score (overall amputation situation). 
Ambulation ability was assessed at baseline and at 6 and 12 
months using the standard “Timed Up and Go” (TUG) and the 
6-minute walk test (6MWT). The Amputee Mobility Predic-
tor assessment tool was used to classify mobility, measured 
as “K-levels”, graded from K-0 (does not have the ability to 
ambulate) to K-4 (active adult) (Gailey et al. 2002). Actual 
activity level was recorded at baseline and 4 months using a 
SenseWear (BodyMedia Inc., Pittsburg, PA), which provided 
the daily average number of steps and also indicators of total 
and active energy expenditure, and duration of physical activ-
ity over a 7-day period of activity (St-Onge et al. 2007).
Statistics
The differences between follow-up values and baseline values 
were calculated in measurement units and as a percentage of 
the baseline value. A Wilcoxon test was used to test for a sta-
tistical difference between baseline and follow-up measures. 
Any p-value of < 0.05 was considered significant. Analyses 
were conducted using SPSS statistical software.
Ethics
The Human Research Ethics Committee of University of 
Notre Dame Australia approved the study (ref. no.: 014153S). 
All the subjects signed an informed consent document.
results
Patient characteristics
The 4 patients were 3 men and 1 woman aged between 38 
and 77 years (Table 1). 1 patient was wheelchair-bound 
and presented with a short residuum (3.8cm). The other 3 
patients presented with difficulty walking with their custom-
ized socket, even for short distances, and they also had radio-
graphic knee arthritis. These 3 patients suffered from socket 
interface problems that reduced their personal, recreational, 
and professional activity level. At the preoperative assess-
ment, the 3 prosthetic users presented with normal posture, 
walked with an antalgic gait, and had skin breakdown at the 
distal end of their residuum. All patients complained of phan-
tom limb sensation and pain. Stage 1 of the procedure for all 4 
cases occurred between August 2012 and April 2014. Patient 
follow-up ranged from 12 to 32 months (and 10–30 months 
after completion of stage 2).
Clinical outcome
All patients had a pain-free knee and no phantom limb sensa-
tion at the follow-up assessment. Case 1 reached maximum 
range of motion of 0–90 degrees, while the others had 0–110 
Table 1. individual and group demographics, amputation information, and rehabilitation timeline 
            
 Demographics  Amputation Rehabilitation timeline
Case Sex Age Height Mass BMI Cause Years since Length of residuum Days between Months between
   (y) (m) (kg)   amputation  (cm)   (%SND) a stage 1 and 2 stage 1 and follow-up 
1 M 38 1.76 70 23 Trauma 4 3.8 10 41 32
2 M 42 1.90 110 31 Trauma 19 9.1 20 42 22
3 M 77 1.82 113 34 Infection 8 15.1 34 27 20
4 F 64 1.57 56 23 Trauma 30 7.3 22 42 12
a
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29–52). Case 1 also showed a marked improvement in the 
mental function component of SF-36 (Table 2, see Supple-
mentary data). 
All cases improved in ambulation and activity levels, 
although no statistically significant difference was apparent 
(Table 2). The improvement in daily number of steps ranged 
from 18% to 730%, and the improvement in duration of physi-
cal activity ranged from 18% to 550%. Case 3 remained at 
level K-3 for mobility (community ambulatory) while cases 
1, 2, and 4 improved their ranking by 4, 2, and 2 levels after 
the procedure to reach the highest K-level (K-4 (active adult)). 
discussion
We report on the feasibility of the first 4 attempts to combine 
total knee replacement with the tibial osseointegrated implant 
for prosthetic attachment in transtibial amputees. 
A short residuum was defined as < 40 mm, based on the 
minimum surface area required for osseointegration, which 
is consistent with other published reports on tibial implants 
(O’Donnell 2009). Our experience suggests a minority of 
transtibial amputees are eligible for this procedure.  Neverthe-
less, they are a challenging group to manage and innovative 
techniques are needed.
A more proximal amputation would be a more straightfor-
ward surgical option, but the knee provides much of the power 
needed for a standard gait cycle (Jefferson et al. 1990). Thus, 
we developed this procedure to offer an important biomechan-
ical advantage over the alternative of a higher-level amputa-
tion, such as a knee disarticulation or transfemoral amputa-
tion. 
In theory, the procedure breaches the conventional princi-
ples of joint replacement by exposing the joint to the environ-
ment, so careful soft tissue management techniques to reduce 
the risk of infection are essential. Initial press-fit implantation 
of the osseointegrated implant is required to provide a proper 
seal of the implant bone interface. Skin healing at the bone is 
essential to prevent ascending infection. 
There have been too few reports of outcomes of osseoin-
tegrated implants for transtibial amputees to compare them 
with outcomes of conventional socket prostheses. However, 
observational data indicate that the success of the implantation 
is related to the length of the residuum, with long residuum 
giving better results than short residuum in case series (Bråne-
mark et al. 2001). Additionally, osseointegrated implants have 
not been used in presence of knee joint arthritis. We observed 
improvement in functional outcomes in our patients. Partici-
pants reported being able to use their prosthesis all through 
the day if needed, which put them at the highest classification 
level using the Amputee Mobility Predictor tool. 
We did not observe any serious adverse events. A superficial 
infection was treated with a single 7-day course of oral antibi-
otics (cephalexin 500 mg). The few authors who have reported 
on the safety of osseointegrated implants have described an 
acceptable rate of superficial infection and rare occurrence of 
other adverse events, including deep infection (Brånemark et 
al. 2014). Altogether, one could hypothesize that the absence 
of stoma revision and explantation surgeries might be due to 
techniques adopted to close pathways from the external envi-
ronment, such as press-fit implantation and soft tissue han-
Figure 3. Skin-implant inter-
face for case 2.
degrees. The implants were 
stable and well aligned (Figure 
4C). All patients had complete 
healing with no discharge at 
the 3-month follow-up, and 
none of the cases presented 
with granulation tissue (Figure 
3). Only case 3 had 1 episode 
of superficial infection and a 
broken bushing (external abut-
ment). 
Functional outcome
All patients improved at 
follow-up for the physical 
component of SF-36 (score 
improvement ranged from 1 
to 54 points) and the Q-TFA 
(score improvement range 
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dling, consequently sealing the knee to ascending infections. 
We are concerned about the risk of deep infection associ-
ated with this procedure. Given the small sample size, limited 
follow-up time, and single-clinic setting, larger prospective 
studies with long-term follow-up will be needed to estimate 
the risks of infection and benefits of this procedure.
Supplementary data
Figure 2 and Table 2 are available available at Acta’s website 
(www.actaorthop.org), identification number 8662.
AK: data collection, data analysis, and led the writing of the manuscript. LF: 
figure preparation, table design, and manuscript review. SL: statistical analy-
sis and manuscript review. BB: data collection. MAM: principal surgeon, con-
ception of study, and writing of the manuscript.
MAM currently has financial consultant agreements with Orthodynamics, 
Endo-Exo Pty Ltd., and Permedica.
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